G-CON selects Pall’s continuous bioprocessing and viral vector tech

By Flora Southey

- Last updated on GMT

(Image: Getty/Pattanaphong Khuankaew)
(Image: Getty/Pattanaphong Khuankaew)

Related tags Pall

G-CON Manufacturing has partnered with Pall Corporation to offer prefabricated cleanrooms for continuous bioprocessing and viral vector production.

According to the agreement, G-CON’s autonomous, mobile facilities, or ‘PODs’, can now be customised with Pall Biotech bioprocessing equipment.

G-CON launched its prefabricated business in October last year​, in collaboration with Integrated Project Services (IPS).

This latest collaboration with Pall delivers “a complete, reproducible, scalable facility solution that is easy to place or relocate, as well as clean, sanitise and even repurpose,” ​said Pall Biotech vice president and general manager, Mario Philips, in an emailed statement.

“This solution addresses customer demand for higher efficiencies while enjoying more flexibility through scale-out and localisation of manufacturing,” ​he added.

According to G-CON, the predesigned PODs, which are integrated with process piping, as well as heating and air conditioning systems, are inherently flexible – the cleanrooms can support multiple products and be repurposed after use.

G-CON and Pall’s offering will compete with GE Healthcare Life Sciences’ KUBio modular bioprocessing facility, which as of April this year​ supports the manufacture of viral vector vaccines.

Related news

Show more

Related products

Trends in Biopharmaceutical Raw Material Selection

Trends in Biopharmaceutical Raw Material Selection

Actylis – The Partner of Choice | 31-Jan-2023 | Business Advice

Join us as our in-house experts, along with Cecile Bellamy from Pfizer, discuss current and future trends in biopharmaceutical raw material selection.

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Related suppliers

Follow us


View more